Clinical Trial Update: Firehawk Rapamycin Target Eluting Coronary Stent North American Trial [NA]

View source ↗

Summary

North American trial of the Firehawk rapamycin-target eluting coronary stent is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Firehawk Rapamycin Target Eluting Coronary Stent (Rapamycin-target eluting coronary stent)

Snippet

Sponsor: Shanghai MicroPort Medical (Group) Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: ACTIVE_NOT_RECRUITING